Added to YB: 2025-03-20
Pitch date: 2025-01-22
TEM [neutral]
Tempus AI, Inc.
-4.87%
current return
Author Info
Golden Bear Capital is where swing trading meets deep research. Sign up for the newsletter.
Company Info
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Market Cap
$8.4B
Pitch Price
$49.72
Price Target
N/A
Dividend
N/A
EV/EBITDA
-57.12
P/E
-33.40
EV/Sales
7.05
Sector
Life Sciences Tools and Services
Category
growth
Scouting the Titans of Tomorrow 🌐
TEM (overview): AI-driven precision medicine platform with 200+ petabytes of data, 50% US oncologist penetration. $693M 2024 revenue (+30% YoY), expanding beyond oncology. Strong pharma partnerships, $900M+ contract value. Ambry acquisition to accelerate growth, profitability by 2025. Risks: pre-profit, competition, regulatory challenges.
Read full article (11 min)